Sleep Treatment Education Program for Cancer Survivors: STEP-Together
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorDana-Farber Cancer Institute
About this trial
This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.
Eligibility criteria
Qualifiers
Age 18-89
History of a cancer diagnosis (except non-melanoma skin cancer) ≥ 6 months prior
No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned.
Significant insomnia as evidenced by an Insomnia Severity Index score ≥ 8
Disqualifiers
Usual bedtime does not fall between 5:00 pm and 5:00 am.
Employment in a position where falling asleep at work could impact public safety (such as air traffic-controller, operating heavy machinery).
Ever diagnosed with Bipolar Disorder or with Seizure Disorder, currently taking medications to prevent a seizure, or have experienced a seizure in the prior 12 months.
Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently.
Trial design
Treatments tested in this trial
- The Sleep Treatment Education Program Together (STEP-Together)
- Coaching Session
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov